v3.26.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIT - USD ($)
$ in Thousands
Total
Class A
Class B
Class C
Common Stock
Common Stock
Class A
Common Stock
Class B
Common Stock
Class C
Treasury Stock
Treasury Stock
Class A
Additional Paid-in Capital
Accumulated Deficit
Non- Controlling Interest
Beginning balance (in shares) at Dec. 31, 2024           15,386,219 815,296 500,000          
Treasury stock, beginning balance (in shares) at Dec. 31, 2024                   965,399      
Beginning balance at Dec. 31, 2024 $ (28,442)       $ 167       $ (11,203)   $ 307,000 $ (327,819) $ 3,413
Increase (Decrease) in Stockholders' and Members' Equity [Roll Forward]                          
Net income (1,511)                     (1,982) 471
Dividends declared (3,504)                     (3,504)  
Stock-based compensation 3,261                   3,261    
Common stock issued under exercise of stock options (in shares)           104,034              
Common stock issued under exercise of stock options 691       1           690    
ESPP shares issued (in shares)           35,288              
ESPP shares issued 289                   289    
Issuance of restricted stock (in shares) [1]           652,193              
Issuance of restricted stock [1] 3,822       7           3,815    
Shares withheld to satisfy tax withholdings (in shares)           (177,915)              
Shares withheld to satisfy tax withholdings (1,432)       (2)           (1,430)    
Ending balance (in shares) at Mar. 31, 2025           15,999,819 815,296 500,000          
Treasury stock, ending balance (in shares) at Mar. 31, 2025                   965,399      
Ending balance at Mar. 31, 2025 (26,826)       173       (11,203)   313,625 (333,305) 3,884
Beginning balance (in shares) at Dec. 31, 2025   16,180,932 815,296 500,000   16,180,932 815,296 500,000          
Treasury stock, beginning balance (in shares) at Dec. 31, 2025   965,399               965,399      
Beginning balance at Dec. 31, 2025 (40,992)       175       (11,203)   319,818 (353,195) 3,413
Increase (Decrease) in Stockholders' and Members' Equity [Roll Forward]                          
Net income 2,957                     2,774 183
Dividends declared (3,967)                     (3,967)  
Stock-based compensation $ 2,739                   2,739    
Common stock issued under exercise of stock options (in shares) 19,500         19,500              
Common stock issued under exercise of stock options $ 130       0           130    
ESPP shares issued (in shares)           37,671              
ESPP shares issued 174                   174    
Issuance of restricted stock (in shares) [2]           1,082,143              
Issuance of restricted stock [2] 2,713       11           2,702    
Ending balance (in shares) at Mar. 31, 2026   17,320,246 815,296 500,000   17,320,246 815,296 500,000          
Treasury stock, ending balance (in shares) at Mar. 31, 2026   965,399               965,399      
Ending balance at Mar. 31, 2026 $ (36,246)       $ 186       $ (11,203)   $ 325,563 $ (354,388) $ 3,596
[1] Refer to Note 8, Stockholders' Deficit, in the accompanying Notes to Unaudited Consolidated Financial Statements for additional information related to restricted stock issued.
[2] Refer to Note 8, Stockholders' Deficit, in the accompanying Notes to Unaudited Consolidated Financial Statements for additional information related to shares issued.